MedPath

Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate Ligament

Not Applicable
Completed
Conditions
Knee Injuries
Interventions
Device: dCELL® ACL Scaffold
Registration Number
NCT02540811
Lead Sponsor
Tissue Regenix Ltd
Brief Summary

The safety and performance of dCELL® ACL Scaffold will be evaluated in 40 patients who have been implanted with the investigational product following a ruptured anterior cruciate ligament (ACL) of the knee.

Detailed Description

The dCELL® ACL Scaffold is a novel device manufactured from porcine tissue using a patented variation of Tissue Regenix's platform technology to render the tissue biocompatible and free from cellular material, providing a biological scaffold that is safe for human implantation whilst preserving the biomechanical properties.

The device is used to reconstruct traumatic ACL tears to help restore normal knee function and therefore prevent further wear of the cartilage and future damage.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients with partial or complete tear of the ACL and require reconstruction of the ACL.
  • Medial Collateral Ligament (MCL) injury grade 2 or less.
  • Osteoarthritis grade 2 or less on the Kellgren Lawrence scale.
  • Patients who have given written informed consent; and are willing and able to comply with entire study procedures including rehabilitation protocol.
Exclusion Criteria
  • Body Mass Index (BMI) greater than 35 kg/m2.
  • Treatment with any investigational drug or device within two months prior to screening.
  • Patients presenting with abnormal degenerative osteoarthritis of the joint.
  • Previous ACL reconstruction on the target knee.
  • Current ACL injury on contralateral knee.
  • Patients using anticoagulants within 2 weeks prior to surgery.
  • Patients on current immuno-suppressive or radiation therapy within six months of screening.
  • Patients with diabetes or cardiovascular disease which precludes elective surgery.
  • Patients with documented renal disease or metabolic bone disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
dCELL® ACL ScaffolddCELL® ACL Scaffold-
Primary Outcome Measures
NameTimeMethod
Arthrometric measurement of knee joint laxityBaseline, 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months

Comparison of the magnitude of side-to-side differences in mm between the treated knee and the opposite normal knee using an arthrometric ligament testing device

Lachman TestBaseline, 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months

Clinical assessment of knee stability

Number of Participants With Treatment-Related Adverse EventsSurgery, 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months

The frequency and seriousness of any adverse events or adverse device effects will be assessed

Pivot Shift TestBaseline, 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months

Clinical assessment of knee stability

Secondary Outcome Measures
NameTimeMethod
Evidence of integration of the investigational product by MRIBaseline, 3 months, 6 months, 12 months, 24 months

Changes to the articular cartilage or joint space at follow up time points compared to pre-surgery

Outcome measure questionnaire of knee functional improvement in terms of symptoms, sport activities and ability to functionBaseline, 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months

Patient's subjective score of 1 to 100 points, with 100 implying the best results and 1 the worst results

Trial Locations

Locations (8)

Robert Jones and Agnes Hunt Hospital NHS Foundation Trust

🇬🇧

Oswestry, Shropshire, United Kingdom

Clifton Park Hospital

🇬🇧

York, North Yorkshire, United Kingdom

Hospital Infanta Elena de Madrid-Valdemoro

🇪🇸

Madrid, Avd. Reyes Catolicos, 21, Spain

Hospital Universitari de Bellvitage

🇪🇸

Barcelona, L'Hospilatet De Llobregat, Spain

Hospital Universitario La Ribera de Alzira

🇪🇸

Valencia, Carretera Corbera, Km1, Spain

Hospital Clinico San Carlos

🇪🇸

Madrid, Calle Profesor Martin Lagos, Spain

Klinika Chirurgii Endoskopowej Sp. z o.o.

🇵🇱

Zory, Ul. Bankowa 2, Poland

Med-Polonia Sp. z o.o.

🇵🇱

Poznan, Ul. Obornicka 262, Poland

© Copyright 2025. All Rights Reserved by MedPath